Pulmonary protective efficacy of S-2[2-aminoethylamino] ethyl phenyl sulphide (DRDE-07) and its analogues against sulfur mustard induced toxicity in mice
•Dermal sulphur mustard (SM) exposure induces pulmonary oxidative stress and inflammation in mice.•SM exposure induces time dependent influx of inflammatory cells to the lung.•MMP-9 level increased in BALF due to SM exposure.•Pretreatment of DRDE-07 and its analogues significantly attenuated the SM...
Gespeichert in:
Veröffentlicht in: | Environmental toxicology and pharmacology 2020-05, Vol.76, p.103333-8, Article 103333 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Dermal sulphur mustard (SM) exposure induces pulmonary oxidative stress and inflammation in mice.•SM exposure induces time dependent influx of inflammatory cells to the lung.•MMP-9 level increased in BALF due to SM exposure.•Pretreatment of DRDE-07 and its analogues significantly attenuated the SM induced pulmonary toxicity.•DRDE-07 and its analogues exhibited their antioxidant and anti-inflammatory properties against SM toxiciity.•The above tested compounds may be effective as prophylactic or therapeutic drug for SM toxicity.
Our previous study showed that percutaneous sulfur mustard (SM) exposure induced pulmonary toxicity, which was attenuated by DRDE-07 (S-2[2-aminoethylamino] ethyl phenyl sulphide) pretreatment. The present study aimed to evaluate the protective efficacy of DRDE-07 and its analogues viz., DRDE-30 (S-2(2-aminoethyl amino)ethyl propyl sulphide) and DRDE-35 (S-2(2-aminoethyl amino)ethyl butyl sulphide) against SM. Thirty minutes before percutaneous SM (0.8 LD50) exposure, female Swiss mice were orally gavaged with DRDE-07 and its analogues(0.2 LD50). Animals were sacrificed on day 3 and 7, BAL fluid (BALF) and lung tissue were collected for biochemical, histopathological studies. As results, DRDE-07 and its analogues were beneficial in reducing the number of BALF inflammatory cells, protein level, lactate dehydrogenase (LDH) activity, myeloperoxidase (MPO) and β-glucuronidase activity, while content of BALF and lung reduced glutathione level (GSH) were significantly protected. The pretreatment of DRDE-07 and its analogues inhibited the recruitment of inflammatory cells into the lung. The beneficial effects of DRDE-07 and its analogues were attributed to their antioxidant and anti-inflammatory activity. Among the analogues, DRDE-30 exhibited significant beneficial effects as compared to the other two compounds. These analogues may be considered as prototype candidate molecules as there is no effective antidote for SM toxicity. |
---|---|
ISSN: | 1382-6689 1872-7077 |
DOI: | 10.1016/j.etap.2020.103333 |